115 related articles for article (PubMed ID: 7245966)
1. [Immunologic activity of the "murine" toxin of the plague microbe in experiments on animals].
Evstigneev VI; Chicherin IuV; Byvalov AA; Pautov VN; Dodonov NP
Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):39-42. PubMed ID: 7245966
[No Abstract] [Full Text] [Related]
2. [A comparative study by immunoblotting of the serological response in white mice and guinea pigs inoculated against plague].
Nekliaev VN; Gamleshko KhP; Rozhkov KK
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):75-6. PubMed ID: 8553775
[No Abstract] [Full Text] [Related]
3. [The characterization of the protective properties of antiplague preparations by using the index of macrophage subpopulation redistribution].
Vasil'eva GI; Tkachenko LN; Verkina LM; Doroshenko EP
Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):94-6. PubMed ID: 7879567
[No Abstract] [Full Text] [Related]
4. [Experimental protective of fraction I of the plague microbe].
Pautov VN; Chicherin IuV; Evstigneev VI; Byvalov AA; Kedrov OA
Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):37-42. PubMed ID: 116458
[TBL] [Abstract][Full Text] [Related]
5. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
[No Abstract] [Full Text] [Related]
6. [Structural and functional properties and the biological activity of Yersinia pestis capsular antigen, murine toxin and endotoxin].
Isin ZhM; Tugambaev TI
Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):91-8. PubMed ID: 3300112
[No Abstract] [Full Text] [Related]
7. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O
Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680
[TBL] [Abstract][Full Text] [Related]
8. [Study of protective properties of antigen-containing liposomes of different lipid composition in plague].
Zakrevskiĭ VI; Plekhanova NG
Vestn Akad Med Nauk SSSR; 1990; (8):41-4. PubMed ID: 2275277
[TBL] [Abstract][Full Text] [Related]
9. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
11. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.
Elvin SJ; Williamson ED
Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741
[No Abstract] [Full Text] [Related]
12. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
[TBL] [Abstract][Full Text] [Related]
13. [Cyto-serologic indices of immunity and their correlation in animals immunized against plague].
Filimonova IA
Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):37-41. PubMed ID: 4141555
[No Abstract] [Full Text] [Related]
14. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
[TBL] [Abstract][Full Text] [Related]
15. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.
Morton M; Garmory HS; Perkins SD; O'Dowd AM; Griffin KF; Turner AK; Bennett AM; Titball RW
Vaccine; 2004 Jun; 22(20):2524-32. PubMed ID: 15193377
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
[TBL] [Abstract][Full Text] [Related]
17. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens].
Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769
[No Abstract] [Full Text] [Related]
18. [The biochemical aspects of the pathogenicity of the causative agent of plague].
Naumov AV; Kuz'michenko IA; Taranenko TM; Korovkin SA; Ermakova GV
Med Parazitol (Mosk); 1995; (4):17-22. PubMed ID: 8587511
[No Abstract] [Full Text] [Related]
19. [Use of monoclonal antibodies to plague microbe antigens at the early stage of infection in white mice for enhancement of the late streptomycin and doxycycline treatment].
Ryzhko IV; Tsuraeva RI; Alekseeva LP; Shcherbaniuk AI; Mishan'kin MB
Antibiot Khimioter; 2003; 48(3):21-5. PubMed ID: 12914117
[TBL] [Abstract][Full Text] [Related]
20. [Cross immunity to plague and tularemia].
Vasenin AS; Veĭnblat VI; Samoĭlova LV
Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):49-52. PubMed ID: 7395403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
